Assertio Holdings (ASRT) Other Working Capital Changes (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Other Working Capital Changes came in at $1.7 million in Q1 2026, down 83.71% year-on-year from $10.4 million in Q1 2025, and down 65.32% quarter-over-quarter from $4.9 million in Q4 2025.
Assertio Holdings (ASRT) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Other Working Capital Changes across 8 years of filings, most recently posting $1.7 million for Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $1.7 million, down 83.71% year-over-year; the trailing twelve-month figure through Mar 2026 was -$9.9 million (down 224.01% YoY), and the FY2025 annual result was -$1.2 million, up 72.1% from the prior year.
- Other Working Capital Changes came in at $1.7 million for Q1 2026 at Assertio Holdings, down from $4.9 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $10.4 million in Q1 2025 to a low of -$14.0 million in Q3 2025.
- The 5-year median for Other Working Capital Changes is -$1.8 million (2023), against an average of -$629117.6.
- Peak annual rise in Other Working Capital Changes reached 642.69% in 2025, while the deepest fall reached 424.59% in 2025.
- Assertio Holdings' Other Working Capital Changes stood at $5.3 million in 2022, then jumped by 50.65% to $7.9 million in 2023, then plunged by 81.25% to $1.5 million in 2024, then jumped by 229.03% to $4.9 million in 2025, then slumped by 65.32% to $1.7 million in 2026.
- The last three Other Working Capital Changes figures came in at $1.7 million (Q1 2026), $4.9 million (Q4 2025), and -$14.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.70 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | 4.90 Mn |
| Dec 31, 2025 | 4.90 Mn |
| Sep 30, 2025 | -14.02 Mn |
| Sep 30, 2025 | -14.02 Mn |
| Jun 30, 2025 | -2.51 Mn |
| Jun 30, 2025 | -2.51 Mn |
| Mar 31, 2025 | 10.43 Mn |
| Mar 31, 2025 | 10.43 Mn |
| Dec 31, 2024 | 1.49 Mn |
| Dec 31, 2024 | 1.49 Mn |
| Sep 30, 2024 | -2.67 Mn |
| Sep 30, 2024 | -2.67 Mn |
| Jun 30, 2024 | -1.23 Mn |
| Jun 30, 2024 | -1.23 Mn |
| Mar 31, 2024 | -1.92 Mn |
| Mar 31, 2024 | -1.92 Mn |
| Dec 31, 2023 | 7.94 Mn |
| Dec 31, 2023 | 7.94 Mn |